APA (7th ed.) Citation

BD, F., BC, K., FD, R., HNC, C., SS, B., IVD, S., . . . I, Z. (2024). Efficacy and safety of onasemnogene abeparvovec for the treatment of patients with spinal muscular atrophy type 1: A systematic review with meta-analysis. PloS one, 19(5), e0302860. https://doi.org/10.1371/journal.pone.0302860

Chicago Style (17th ed.) Citation

BD, Fernandes, Krug BC, Rodrigues FD, Cirilo HNC, Borges SS, Schwartz IVD, Probst LF, and Zimmermann I. "Efficacy and Safety of Onasemnogene Abeparvovec for the Treatment of Patients with Spinal Muscular Atrophy Type 1: A Systematic Review with Meta-analysis." PloS One 19, no. 5 (2024): e0302860. https://doi.org/10.1371/journal.pone.0302860.

MLA (9th ed.) Citation

BD, Fernandes, et al. "Efficacy and Safety of Onasemnogene Abeparvovec for the Treatment of Patients with Spinal Muscular Atrophy Type 1: A Systematic Review with Meta-analysis." PloS One, vol. 19, no. 5, 2024, p. e0302860, https://doi.org/10.1371/journal.pone.0302860.